- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01602978
Comparison of Pulse Hemoglobin and Pleth Variability Index (Pleth)
March 1, 2019 updated by: Davinder Ramsingh, MD, Loma Linda University
Comparison of Pulse Hemoglobin and Pleth Variability Index to Standard Methods of Guiding Intraoperative Fluid and Transfusion Management During Major Surgical Procedures.
The purpose of this study is to investigate whether a validated sensor that is able to measure how much oxygen-carrying molecules called hemoglobin using pulse hemoglobin and Pleth Variability Index (PVI)] are in your blood during surgery can help your doctors manage how much fluid and possibly blood you need to get during your surgery.
The hope of the study is that the device may provide an early indication you are having bleeding and this may mean you need to be treated with a transfusion.
Our current method of checking this is by getting a blood sample for analysis.
The investigators hope is that this device may be able to alert the clinician of the need for blood or fluids without a blood draw being needed.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
299
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Loma Linda, California, United States, 92354
- Loma Linda University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The study population will be adults more than 18 years old that are scheduled for a major surgical procedure.
Description
Inclusion Criteria:
- Subjects must be >18 years old;
- must be having a major surgical procedure;
- The pre-operative estimation of blood loss must be at least 15% of the total blood volume
Exclusion Criteria:
- Does subject have hemoglobinopathy;
- cardiac arrhythmias producing irregular rhythms;
- severe pulmonary disease;
- procedures where loss of more that 10 to 15% of total blood volume is unlikely;
- subject refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The difference between hemoglobin values from the two monitors.
Time Frame: Pulse hemoglobin will be monitored during the surgery from the first arterial blood gas drawn to the last ABG drawn.
|
The primary outcome measure is the difference between hemoglobin values from the pulse oximetry device and from the arterial blood gas co-oximeter.
|
Pulse hemoglobin will be monitored during the surgery from the first arterial blood gas drawn to the last ABG drawn.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference between measures compared to patient characteristics
Time Frame: Start of surgery to end of surgery
|
Secondary outcome measures are the size of difference between measures compared to patient characteristics.
|
Start of surgery to end of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (ACTUAL)
February 13, 2018
Study Completion (ACTUAL)
February 13, 2018
Study Registration Dates
First Submitted
March 1, 2012
First Submitted That Met QC Criteria
May 17, 2012
First Posted (ESTIMATE)
May 21, 2012
Study Record Updates
Last Update Posted (ACTUAL)
March 4, 2019
Last Update Submitted That Met QC Criteria
March 1, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 5100032
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Italy, Spain, United Kingdom, Hungary
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Netherlands, Germany, Italy, United Kingdom, United States, France
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingSevere Aplastic Anemia | Refractory Aplastic Anemia | Newly Diagnosed Aplastic Anemia
-
China Immunotech (Beijing) Biotechnology Co., Ltd.Not yet recruitingAutoimmune Hemolytic AnemiaChina
-
Peking Union Medical College HospitalNot yet recruiting
-
Chinese PLA General HospitalBeijing Friendship Hospital; Beijing 302 Hospital; The University of Hong Kong-Shenzhen... and other collaboratorsEnrolling by invitationSevere Aplastic Anemia | Severe Aplastic Anemia (SAA) | Severe Aplastic Anemia, RefractoryChina
-
Incyte CorporationTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom, Belgium
-
Chen MiaoNot yet recruiting